Therapeutic failure with itraconazole in sporotrichosis due to bariatric surgery
Author(s) -
Larissa Crestani,
Bruno de Castro e Souza,
Priscila Kakizaki,
Neusa Yuriko Sakai Valente
Publication year - 2020
Publication title -
anais brasileiros de dermatologia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.461
H-Index - 44
eISSN - 1806-4841
pISSN - 0365-0596
DOI - 10.1016/j.abd.2019.04.015
Subject(s) - sporotrichosis , itraconazole , dimorphic fungus , medicine , context (archaeology) , sporothrix schenckii , antifungal , surgery , lymphatic system , dermatology , pathology , biology , paleontology , genetics , yeast
Sporotrichosis is a deep mycosis of subacute or chronic evolution, caused by the dimorphic fungus of the genus Sporothrix. The treatment is carried out with antifungal orally or intravenously. Therapeutic success can be affected by several factors, such as altered gastrointestinal physiology by surgery. More and more patients are submitted to bariatric surgeries and the literature for the alterations of the absorption of medications in this context is very scarce. We intend to contribute to a better understanding with this case report of cutaneous-lymphatic sporotrichosis in a patient after bariatric surgery without response to itraconazole treatment, even at high doses.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom